BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30345164)

  • 1. Update in the Management of Macular Edema Following Retinal Vein Occlusions.
    Thorell MR; Goldhardt R
    Curr Ophthalmol Rep; 2016 Mar; 4(1):38-47. PubMed ID: 30345164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photocoagulation for retinal vein occlusion.
    Hayreh SS
    Prog Retin Eye Res; 2021 Nov; 85():100964. PubMed ID: 33713810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ischemia and laser photocoagulation in retinal vein occlusion].
    Rehak M; Storch MW; Hattenbach LO; Feltgen N
    Ophthalmologie; 2022 Nov; 119(11):1121-1128. PubMed ID: 36357589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the One-Year Efficacy of Combined Anti-VEGF and Dexamethasone Implant Treatment for Macular Edema in Retinal Vein Occlusions.
    Ren F; Gong H; Zhang H; Zhang X; Liu X; Li J; Zhang G
    Med Sci Monit; 2023 Jun; 29():e939277. PubMed ID: 37301978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.
    Feng XX; Li C; Shao WW; Yuan YG; Qian XB; Zheng QS; Li YJ; Gao QY
    Int J Ophthalmol; 2018; 11(3):429-437. PubMed ID: 29600177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinal vein thrombosis: pathogenesis and management.
    Rehak M; Wiedemann P
    J Thromb Haemost; 2010 Sep; 8(9):1886-94. PubMed ID: 20492457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroids and macular edema from retinal vein occlusion.
    Glacet-Bernard A; Coscas G; Zourdani A; Soubrane G; Souied EH
    Eur J Ophthalmol; 2011; 21 Suppl 6():S37-44. PubMed ID: 23264327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Mitry D; Bunce C; Charteris D
    Cochrane Database Syst Rev; 2013 Jan; (1):CD009510. PubMed ID: 23440840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of posterior sub-tenon triamcinolone in macular edema due to non-ischemic vein occlusions.
    Gurram MM
    J Clin Diagn Res; 2013 Dec; 7(12):2821-4. PubMed ID: 24551647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and effectiveness of anti-VEGF or steroids monotherapy versus combination treatment for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.
    Zhang W; Liu Y; Sang A
    BMC Ophthalmol; 2022 Dec; 22(1):472. PubMed ID: 36474156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion.
    Shalchi Z; Mahroo O; Bunce C; Mitry D
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD009510. PubMed ID: 32633861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of macular edema secondary to branch retinal vein occlusion: an evidence-based update.
    Aref AA; Scott IU
    Adv Ther; 2011 Jan; 28(1):28-39. PubMed ID: 21153509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion.
    Gewaily D; Muthuswamy K; Greenberg PB
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007324. PubMed ID: 26352007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of anti-VEGF treatment of macular oedema due to retinal vein occlusions.
    Corazza P; D'Alterio FM; Savastano MC; Kabbani J; Duguid G; Savastano A; Younis S
    Eur J Ophthalmol; 2022 Nov; 32(6):3536-3546. PubMed ID: 35253456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficiency of anti-VEGF drugs intravitreal injections treatment with or without retinal laser photocoagulation for macular edema secondary to retinal vein occlusion: A systematic review and meta-analysis.
    Zou W; Du Y; Ji X; Zhang J; Ding H; Chen J; Wang T; Ji F; Huang J
    Front Pharmacol; 2022; 13():948852. PubMed ID: 35935843
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
    Zhang H; Xia Y
    Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal Vein Occlusion.
    Sawada O; Ohji M
    Dev Ophthalmol; 2016; 55():147-53. PubMed ID: 26501219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
    Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
    JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
    Hu Q; Li H; Xu W; Du Y; Ma C; He J
    Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.